Note of Intent to Award Sole Source
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency Contracting Agency (DHACA), on behalf of the Warfighter Protection and Acute Care Project Management Office (WPAC PMO), is issuing a Notice of Intent to Modify an Existing Contract within Scope on a sole source basis. This notice is not a request for proposals. The modification aims to increase the cost ceiling of contract W81XWH-20-C-0030-P00021 to cover activities necessary for Food and Drug Administration (FDA) Emergency Use Authorization (EUA) and to serve as the Investigational New Drug (IND) application #14047 holder and regulatory sponsor.
Purpose & Rationale for Sole Source
DHACA intends to modify the existing contract to ensure the continued progress of critical activities related to FDA authorization. Market research conducted on April 24, 2026, indicated that no other FDA-licensed companies or intellectual property exist for the specific product (CPP) in question. While the Netherlands Armed Forces utilize CPP, no controlled data analyses are available, necessitating FDA approval. Furthermore, no other U.S. companies were identified as capable of manufacturing the product and completing FDA licensure.
Anticipated Additional Activities & Costs
The contract modification will cover:
- Additional consultant costs
- Additional professional travel
- Additional regulatory costs
Contract Details
- Existing Contract: W81XWH-20-C-0030-P00021
- NAICS Code: 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology))
- Size Standard: 1,250 employees
- Department/Agency: DEPT OF DEFENSE / DEFENSE HEALTH AGENCY (DHA)
- Office: ARMY MED RES ACQ ACTIVITY
- Place of Performance: Frederick, MD
Response Requirements
This is not a request for proposals. However, any sources that believe they are eligible and capable of providing these services must respond in writing with clear and convincing evidence of their ability to provide the required items. Responses are due within fifteen (15) days of this notice's publication.
Deadlines & Contacts
- Notice Published: May 28, 2026
- Responses Due: June 12, 2026 (within 15 days of publication)
- Questions Due: June 12, 2026, by 3:00 PM Eastern Time
- Primary Contact: Peter Mitchell (peter.d.mitchell8.civ@health.mil)